Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX-PAD in Intermittent Claudication
NCT01679990Phase 2Completed
- Sponsor
- Pluri Inc.
- Start
- Nov 2012
- Primary completion
- Mar 2018
- Modality
- Mesenchymal Stem Cells
- Countries
- 4
01
Overview
A Phase 2 trial of PLX-PAD in intermittent claudication (IC), sponsored by Pluri Inc.. Started Nov 2012; status: completed.
02
Drugs
PLX-PAD
03
Conditions
intermittent claudication (IC)
Beyond the preview
Go deeper on NCT01679990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01679990.